← Leaderboards
Irina Agoulnik
Baylor College Of Medicine
$1,061,358
Attributed
$1,479,012
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $418.1K · FY2008–24$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,479,012 · 4
By mechanism
R21$752,160 · 2
R15$418,144 · 1
R41$308,708 · 1
Top collaborators
- Alexander I. Agoulnik3 shared
- Peter S Distefano1 shared
- Ronald Lindsay1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Norman Michael Greenberg$14,007,258
- Alexander I. Agoulnik$7,344,882
- Thomas Wheeler$174,672
- Jianming Xu$13,357,961
- Santosh A Helekar$597,931
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAgonistRecombinantsAffectTissuesCancer CellPreventLeadMediatingPropertyResponsePathway InteractionsCancer PatientCellsHormonesMouse ModelIn VivoLaboratoriesCell ProliferationOrganBaseCancer ModelGrowthAndrogens
Grant awards (7)
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor$199,856
R21 · FY2024 · CA · contact PI
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor$172,391
R21 · FY2023 · CA · contact PI
Engineering a long-acting relaxin agonist to treat liver fibrosis$308,708
R41 · FY2021 · DK
Regulation of metastases by tumor suppressor INPP4B$418,144
R15 · FY2014 · CA · contact PI
Role of NCoR in Antiandrogen Resistance in Prostate Cancer$162,000
R21 · FY2009 · CA · contact PI
Role of NCoR in Antiandrogen Resistance in Prostate Cancer$10,688
R21 · FY2009 · CA · contact PI
Role of NCoR in Antiandrogen Resistance in Prostate Cancer$207,225
R21 · FY2008 · CA · contact PI